IBM said on Thursday it will spend $240 million over the next decade to fund a new artificial intelligence research lab at the Massachusetts Institute of Technology. The resulting MIT–IBM Watson AI Lab will focus on a handful of key AI areas including the development of new "deep learning" algorithms. Deep learning is a subset of AI that aims to bring human-like learning capabilities to computers so they can operate more autonomously. The Cambridge, Mass.-based lab will be led by Dario Gil, vice president of AI for IBM Research and Anantha Chandrakasan, dean of MIT's engineering school. It will draw upon about 100 researchers from IBM (ibm) itself and the university.
IBM Watson Health has formed a medical imaging collaborative with more than 15 leading healthcare organizations. The goal: To take on some of the most deadly diseases. The collaborative, which includes health systems, academic medical centers, ambulatory radiology providers and imaging technology companies, aims to help doctors address breast, lung, and other cancers; diabetes; eye health; brain disease; and heart disease and related conditions, such as stroke. Watson will mine insights from what IBM calls previously invisible unstructured imaging data and combine it with a broad variety of data from other sources, such as data from electronic health records, radiology and pathology reports, lab results, doctors' progress notes, medical journals, clinical care guidelines and published outcomes studies. As the work of the collaborative evolves, Watson's rationale and insights will evolve, informed by the latest combined thinking of the participating organizations.
Two years after originally announcing it, Medtronic and IBM Watson have launched their joint platform the Sugar.IQ, a digital diabetes assistant. "It is designed for people who are currently using Guardian Connect; so made for people on multiple daily injections. It is a personal assistant a little bit like Alexa or Siri," Huzefa Neemuchwala, global head of digital health solutions and AI at Medtronic, said in a Facebook live informational session. "It is an intelligent assistant that keeps track of all of your information and has all of your information in one place. Then through Watson technology we use this information to power insights so we can better manage your diabetes so that you can spend more time in range."
IBM Watson burst onto the scene in 2011 as a Jeopardy-playing computer and quickly became synonymous with artificial intelligence. Since then, AI has become a lot more commonplace thanks to the rise of digital assistants like Siri, Amazon's Alexa and Google Assistant, but Watson is still chugging away in more ways than you might think, powering everything from cancer treatment software to hotel concierge robots (pictured above). I had a chance to talk to Maya Weinstein, Senior Interaction Design and Creative Director at IBM Watson, about everything from the current crop of AI assistants to how the technology can help save lives. Check out the full interview (with some light edits for clarity) below. Jacob Kleinman: What do you think of the rise of consumer AI products like chatbots or Amazon Echo?
WIRED Health 2016 takes place on 29 April in London. IBM's Watson supercomputer is perhaps best known for winning the gameshow Jeopardy, but its expertise is now being applied to healthcare Kyu Rhee will be speaking at WIRED Health 2016 on 29 April in London. From helping humans live longer to understanding the brain, WIRED Health will hear from the innovators transforming this critical sector. You might know IBM's Watson best for its victory on US game show Jeopardy!, or perhaps for its cookery prowess, or even the campaign to elect it to the US presidency. But IBM hopes that its supercomputer can also change the way doctors diagnose their patients, putting vast quantities of data at a physician's fingertips.